AzTrials
AzTrials

Coronary Artery Bypass Graft (CABG)IS/ IMTNCT07367945

Incentive Spirometry Versus Inspiratory Muscle Training After Coronary Artery Bypass Grafting

A study testing Incentive spirometry, Inspiratory muscle trainer and Routine physical therapy in people with Coronary Artery Bypass Graft (CABG), run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will be conducted to compare between incentive spirometry verses inspiratory muscle training preoperatively on (ABG) after coronary artery bypass graft surgery. Is there any significant difference of preoperative incentive spirometry verses inspiratory muscle training on Arterial blood gases (ABG) after… Read more about this study

Who is it for?
Ages 50 to 60 years, men only
Conditions the study is for
Coronary Artery Bypass Graft (CABG)
What is being tested?
Incentive spirometry, Inspiratory muscle trainer and Routine physical therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteEgypt
Study dates
1 Feb 2026to 1 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 45 male patients will be included in this study.
  • Patients with age from 50 to 60 years old (undergoing coronary artery bypass graft surgery) through median sternotomy.
  • Their body mass index from 25 to 29.9 kg/m2
  • Patients will be alert and able to follow instruction.

Who cannot join

  • Who are expected not to be able to conduct or comply with IS and IMT.
  • Patients with cognitive or neurological deficits.
  • Patients with coexisting acute or chronic respiratory disorders.
  • Patients unable to understand or show the proper use of the incentive spirometer and Inspiratory muscle training .
  • Patients who cannot be instructed or supervised to assure appropriate use of the device patients in whom cooperation is absent or patients unable to understand or demonstrate proper use of the devices (inspiratory muscle training and incentive spirometry).
  • Patients who are confused or delirious.
Show all 9Show fewer
  • Patients undergoing any other surgery along with CABG.
  • Patients undergoing emergency CABG surgery.
  • Chronic obstructive pulmonary disease (COPD), asthma, restrictive lung disease, preoperative major chest infection e.g. pulmonary tuberculosis, chest deformities such as pectus carinatum, pectus excavatum, thoracolumbar scoliosis, diaphragmatic hernias diagnosed on history.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Zagazig University Hospitals

    Zagazig, Alsharqia, 44519

Other trials in Egypt

About this study

Official title: Effect of Preoperative Incentive Spirometry Versus Inspiratory Muscle Training on Arterial Blood Gases After Coronary Artery Bypass Grafting

This study will be conducted to compare between incentive spirometry verses inspiratory muscle training preoperatively on (ABG) after coronary artery bypass graft surgery.

Is there any significant difference of preoperative incentive spirometry verses inspiratory muscle training on Arterial blood gases (ABG) after coronary artery bypass graft surgery?

Participants will:

Group A (incentive spirometry group ) Group B (Inspiratory muscle trainer group ) for 5 days before operative Group C (control group) and group a , b will have routinely postoperative

Being tested
Incentive spirometry, Inspiratory muscle trainer, Routine physical therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Incentive spirometryDevice

    Also called IS

    This group will include 15 patients, Incentive spirometry was utilized by the patient with ten breaths, six sets per day for a period of 10 min within patient tolerance in every session for five days with routinely physical therapy program (education and explanation) preoperatively, And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).

  • Inspiratory muscle trainerDevice

    Also called IMT

    This group will include 15 patients, each session consisted of 30 minutes of inspiratory muscle training. The patients were trained to use an inspiratory threshold-loading device (Threshold Inspiratory Muscle Training) for five days with routinely physical therapy program (education and explanation) preoperatively, And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).

  • Routine physical therapyOther

    Also called Control group

    15 patients will receive for 5 days routinely physical therapy program (education and explanation) preoperatively, And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).

Study groups in NCT07367945
Study groupRoleWhat they receive
ISExperimentalThis group will include 15 patients, Incentive spirometry was utilized by the patient with ten breaths, six sets per day for a period of 10 min within patient tolerance in every session for five days with routinely physical therapy program (education and explanation) preoperatively, And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).
Receives: Device: Incentive spirometry
IMTExperimentalThis group will include 15 patients, each session consisted of 30 minutes of inspiratory muscle training. The patients were trained to use an inspiratory threshold-loading device (Threshold Inspiratory Muscle Training) for five days with routinely physical therapy program (education and explanation) preoperatively, two times per day. And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).
Receives: Device: Inspiratory muscle trainer
Control groupActive comparator15 patients will receive for 5 days routinely physical therapy program (education and explanation) preoperatively, And postoperatively treatment (breathing treatment, deep-breathing applications, guided coughing, early mobilization).
Receives: Other: Routine physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Arterial Blood gas Parameters (PaO2 and SaO2)

    Assessment of arterial oxygenation changes by measuring PaO2 and SaO2 . data will be collected at Baseline pre-surgery (5 days ) , Immediately after the surgery (within 48 hours) , and through study completion an average of 8 days. to evaluate the recovery trend and the effectiveness of respiratory interventions.

    Measured: Baseline 5 days pre-surgery , Immediately after the surgery within 48 hours , and through study completion an average of 8 days.

  2. Numerical rating pain scale

    Pain Scale for Pain Assessment. data will be collected at Baseline pre-surgery (5 days ) , Immediately after the surgery (within 48 hours) , and through study completion an average of 8 days. to evaluate the recovery trend and the effectiveness of respiratory interventions.

    Measured: Baseline 5 days pre-surgery , Immediately after the surgery within 48 hours , and through study completion an average of 8 days.

Secondary outcomes (2)
  1. Functional capacity (2- minute walk test)

    measuring the maximum distance a patient can walk on a flat surface in 2-minutes to evaluate functional exercise capacity.

    Measured: Baseline 5 days pre-surgery, and through study completion an average of 8 days.

  2. Physical function ICU test - scored (PFIT-s)

    Assessment of physical function in the ICU through four components ( sit -to- stand, marching, shoulder flexion, and knee extension ) Scored (0 - 10).

    Measured: Immediately after the surgery within 48 hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2026
  2. Study start1 Feb 2026
  3. Primary completion1 May 2026
  4. Study completion1 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07367945
Sponsor's protocol ID
P.T.REC/012/006065
Acronym
IS/ IMT
Status last verified
Dec 2025
First submitted
6 Jan 2026
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: data is available with a corresponding offer on reasonable request

Questions about this trial

What is this clinical trial studying?

A study testing Incentive spirometry, Inspiratory muscle trainer and Routine physical therapy in people with Coronary Artery Bypass Graft (CABG), run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Arterial Blood gas Parameters (PaO2 and SaO2) (time frame: Baseline 5 days pre-surgery , Immediately after the surgery within 48 hours , and through study completion an average of 8 days.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in